Pretreatment prediction of symptom response to proton pump inhibitor therapy (Q39023140)

8 September 2017

Pretreatment prediction of symptom response to proton pump inhibitor therapy (English)

1 reference

8 September 2017

Akihito Nagahara

1

1 reference

8 September 2017

Hiroto Miwa

2

1 reference

8 September 2017

Daisuke Asaoka

3

1 reference

8 September 2017

Yuji Shimada

4

1 reference

8 September 2017

Hitoshi Sasaki

5

1 reference

8 September 2017

Kenshi Matsumoto

6

1 reference

8 September 2017

Taro Osada

7

1 reference

8 September 2017

Mariko Hojo

8

1 reference

8 September 2017

Sumio Watanabe

9

1 reference

8 September 2017

1 March 2015

1 reference

Journal of Gastroenterology and Hepatology

8 September 2017

1 reference

8 September 2017

30 Suppl 1

1 reference

8 September 2017

25-30

1 reference

Observational comparative trial of the efficacy of proton pump inhibitors versus histamine-2 receptor antagonists for uninvestigated dyspepsia

8 September 2017

1 reference

Efficacy of omeprazole, famotidine, mosapride and teprenone in patients with upper gastrointestinal symptoms: an omeprazole-controlled randomized study (J-FOCUS).

21 January 2018

1 reference

Is it possible to predict treatment response to a proton pump inhibitor in functional dyspepsia?

21 January 2018

1 reference

Randomized-controlled trial of esomeprazole in functional dyspepsia patients with epigastric pain or burning: does a 1-week trial of acid suppression predict symptom response?

21 January 2018

1 reference

Prevalence of overlaps between GERD, FD and IBS and impact on health-related quality of life.

21 January 2018

1 reference

Characteristics of Japanese patients with chronic gastritis and comparison with functional dyspepsia defined by ROME III criteria: based on the large-scale survey, FUTURE study

21 January 2018

1 reference

Therapeutic effects of famotidine on chronic symptomatic gastritis: subgroup analysis from FUTURE study

21 January 2018

1 reference

Investigation of pretreatment prediction of proton pump inhibitor (PPI)-resistant patients with gastroesophageal reflux disease and the dose escalation challenge of PPIs-TORNADO study: a multicenter prospective study by the Acid-Related Symptom Rese

21 January 2018

1 reference

Impairment of health-related quality of life in functional dyspepsia and chronic liver disease: the influence of depression and anxiety.

21 January 2018

1 reference

Anxiety, personality traits and quality of life in functional dyspepsia-suffering patients

21 January 2018

1 reference

Onset of relief of symptoms of gastroesophageal reflux disease: post hoc analysis of two previously published studies comparing pantoprazole 20 mg once daily with nizatidine or ranitidine 150 mg twice daily

21 January 2018

1 reference

Rabeprazole vs esomeprazole in non-erosive gastro-esophageal reflux disease: a randomized, double-blind study in urban Asia.

21 January 2018

1 reference

Efficacy of rabeprazole on heartburn symptom resolution in patients with non-erosive and erosive gastro-oesophageal reflux disease: a multicenter study from Japan

21 January 2018

1 reference

Predicting the efficacy of proton pump inhibitors in patients with non-erosive reflux disease before therapy using dual-channel 24-h esophageal pH monitoring

21 January 2018

1 reference

Randomised clinical trial: rabeprazole improves symptoms in patients with functional dyspepsia in Japan

21 January 2018

1 reference

Epidemiology of functional dyspepsia: a global perspective

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JGH.12744

1 reference

8 September 2017

1 reference